Stem cells: Therapeutic present and future

Drug News and Perspectives

Volumn 20, Issue 2, 2007, Pages 119-128

  Khurdayan, Valeria K ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CTCE 0214; GRANULOCYTE COLONY STIMULATING FACTOR; MOZOBIL; PLACEBO; PLERIXAFOR; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CROHN DISEASE; EMBRYONIC STEM CELL; HEART FAILURE; HEMATOLOGIC DISEASE; HUMAN; KIDNEY CARCINOMA; LIVER CIRRHOSIS; MESENCHYMAL STEM CELL; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; NONHUMAN; REVIEW; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; STROKE; ANIMAL; HISTORY; MASS COMMUNICATION; PHENOTYPE; PHYSIOLOGY; REGENERATION; REGENERATIVE MEDICINE; STEM CELL; STEM CELL RESEARCH; TRENDS;

ANIMALS; DIFFUSION OF INNOVATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PHENOTYPE; REGENERATION; REGENERATIVE MEDICINE; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 34250348826     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2007.20.2.1083433     Document Type: Review

References (70)

1. Bongso, A. Blastocyst culture for deriving human embryonic stem cells. Methods Mol Biol 2006, 331: 13-22.
2. Bianco, P., Kuznetsov, S.A., Riminucci, M. and Gehron, R.P. Postnatal skeletal stem cells. Methods Enzymol 2006, 419: 117-48.
3. Bickenbach, J.R., Stern, M.M., Grinnell, K.L., Manuel, A. and Chinnathambi, S. Epidermal stem cells have the potential to assist in healing damaged tissues. J Investig Dermatol Symp Proc 2006, 11: 118-23.
4. Klimanskaya, I., Chung, Y., Becker, S., Lu, S.J. and Lanza, R. Human embryonic stem cell lines derived from single blastomeres. Nature 2006, 444: 481-5.
5. Zhang, J., Tam, W.L., Tong, G.Q. et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 2006, 8: 1114-23.
6. Baylis, F. and Robert, J.S. Human embryonic stem cell research: An argument for national research review. Account Res 2006, 13: 207-24.
7. Mimeault, M. and Batra, S.K. Concise review: Recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 2006, 24: 2319-45.
8. Bowens, K.K. The legal status of embryos and implications for reproductive technologies and biotechnology research. J Biolaw Bus 2006, 9: 17-25.
9. Guo, X.M., Wang, C.Y., Tian, X.C. and Yang, X. Engineering cardiac tissue from embryonic stem cells. Methods Enzymol 2006, 420: 316-38.
10. Cohen, S., Leshanski, L. and Itskovitz-Eldor, J. Tissue engineering using human embryonic stem cells. Methods Enzymol 2006, 420: 303-15.
11. Eberli, D. and Atala, A. Tissue engineering using adult stem cells. Methods Enzymol 2006, 420: 287-302.
12. Lunde, K., Solheim, S., Aakhus, S. et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355: 1199-209.
13. Schachinger, V., Erbs, S., Elsasser, A. et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355: 1210-21.
14. Jiang, W., Ma, A., Wang, T. et al. Intravenous transplantation of mesenchymal stem cells improves cardiac performance after acute myocardial ischemia in female rats. Transpl Int 2006, 19: 570-80.
15. Tang, J., Xie, Q., Pan, G., Wang, J. and Wang, M. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur J Cardiothorac Surg 2006, 30: 353-61.
16. Zavos, P.M. Stem cells and cellular therapy: Potential treatment for cardiovascular diseases. Int J Cardiol 2006, 107: 1-6.
17. Engelmann, M.G., Theiss, H.D., Hennig-Theiss, C. et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: Final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2006, 48: 1712-21.
18. Engelmann, M.G. and Franz, W.M. Stem cell therapy after myocardial infarction: Ready for clinical application? Curr Opin Mol Ther 2006, 8: 396-414.
19. Arguero, R., Careaga-Reyna, G., Castano-Guerra, R., Garrido-Garduno, M.H., Magana-Serrano, J.A. and J. Nambo-Lucio, M. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Arch Med Res 2006, 37: 1010-4.
20. Kang, H.J., Lee, H.Y., Na, S.H. et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: The MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006, 114(1 Suppl): 1145-51.
21. Nishiyama, N. Human umbilical cord blood derived mesenchymal stem cell has a powerful cardiomyogenic potential in vitro: A novel cell source for cardiac stem cell-based therapy. J Am Coll Cardiol 2006, 47 (4, Suppl. 1):Abst 921-107.
22. Matthias, N. Effect of stem cells on left ventricle wall thickness and capillary density in pigs following myocardial infarction. J Am Coll Cardiol 2006, 47(4, Suppl. 1): Abst 829-3.
23. Lindvall, O. and Kokaia, Z. Stem cells for the treatment of neurological disorders. Nature 2006, 441: 1094-6.
24. Oliveira, A.A., Jr. and Hodges, H.M. Alzheimer's disease and neural transplantation as prospective cell therapy. Curr Alzheimer Res 2005, 2: 79-95.
25. Ikeda, R., Kurokawa, M.S., Chiba, S. et al. Transplantation of neural cells derived from retinoic acid-treated cynomolgus monkey embryonic stem cells successfully improved motor function of hemiplegic mice with experimental brain injury. Neurobiol Dis 2005, 20: 38-48.
26. Ben Hur, T. Human embryonic stem cells for neuronal repair. Isr Med Assoc J 2006, 8: 122-6.
27. Kerr, D.A., Llado, J., Shamblott, M.J. et al. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci 2003, 23: 5131-40.
28. Bang, O.Y., Lee, J.S., Lee, P.H. and Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005, 57: 874-82.
29. Olanow, C.W., Goetz, C.G., Kordower, J.H. et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003, 54: 403-14.
30. Piccini, P., Pavese, N., Hagell, P. et al. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128(Pt 12): 2977-86.
31. Liu, Z. and Martin, L.J. The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain. J Comp Neurol 2006, 497: 468-88.
32. Nayak, M.S., Kim, Y.S., Goldman, M., Keirstead, H.S. and Kerr, D.A. Cellular therapies in motor neuron diseases. Biochim Biophys Acta 2006, 1762: 1128-38.
33. Mazzini, L., Mareschi, K., Ferrero, I. et al. Autologous mesenchymal stem cells: Clinical applications in amyotrophic lateral sclerosis. Neurol Res 2006, 28: 523-6.
34. de Hemptinne, I, Boucherie, C., Pochet, R. et al. Unilateral induction of progenitors in the spinal cord of hSOD1(G93A) transgenic rats correlates with an asymmetrical hind limb paralysis. Neurosci Lett 2006, 401: 25-9.
35. Lambrechts, D. and Carmeliet, P. VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease. Biochim Biophys Acta 2006, 1762(11-12): 1109-21.
36. Garbossa, D., Fontanella, M., Fronda, C. et al. New strategies for repairing the injured spinal cord: The role of stem cells. Neurol Res 2006, 28: 500-4.
37. Huang, F., Wang, J. and Chen, A. Effects of co-grafts mesenchymal stem cells and nerve growth factor suspension in the repair of spinal cord injury. J Huazhong Univ Sci Technolog Med Sci 2006, 26: 206-10.
38. Liang, P., Jin, L.H., Liang, X, Liu, E.Z. and Zhao, S.G Human neural stem cells promote corticospinal axons regeneration and synapse reformation in injured spinal cord of rats. Chin Med J (Engl) 2006, 119: 1331-8.
39. Moviglia, G.A., Fernandez, V.R., Brizuela, J.A. et al. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy 2006, 8: 202-9.
40. Deshpande, D.M., Kim, Y.S., Martinez, T. et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 2006, 60: 32-44.
41. Dietrich, J. and Kempermann, G. Role of endogenous neural stem cells in neurological disease and brain repair. Adv Exp Med Biol 2006, 557: 191-220.
42. Hayashi, J., Takagi, Y., Fukuda, H. et al. Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain. J Cereb Blood Flow Metab 2006, 26: 906-14.
43. Robin, A.M., Zhang, Z.G., Wang, L. et al. Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab 2006, 26: 125-34.
44. Shyu, W.C., Lee, Y.J., Liu, D.D., Lin, S.Z. and Li, H. Homing genes, cell therapy and stroke. Front Biosci 2006, 11: 899-907.
45. Yasuhara, T., Borlongan, C.V. and Date, I. Ex vivo gene therapy: Transplantation of neurotrophic factor-secreting cells for cerebral ischemia. Front Biosci 2006, 11: 760-75.
46. Aschan, J. Allogeneic haematopoietic stem cell transplantation: Current status and future outlook. Br Med Bull 2006, 77-78: 23-36.
47. Bensinger, W.I. The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma. Leukemia 2006, 20: 1683-9.
48. Bethge, W.A., Haegele, M., Faul, C. et al. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: Fast engraftment and low toxicity. Exp Hematol 2006, 34: 1746-52.
49. Hertzberg, M., Grigg, A., Gottlieb, D. et al. Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders. Bone Marrow Transplant 2006, 37: 923-8.
50. Hill, G.R., Morris, E.S., Fuery, M. et al. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF. Biol Blood Marrow Transplant 2006, 12: 603-7.
51. Abuljadayel, I.S., Quereshi, H., Ahsan, T. et al. Infusion of autologous retrodifferentiated stem cells into patients with beta-thalassemia. ScientificWorldJournal 2006, 6: 1278-97.
52. Barkholt, L., Bregni, M., Remberger, M. et al. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Ann Oncol 2006, 17: 1134-40.
53. Yuan, X., Hu, J., Belladonna, M.L., Black, K.L. and Yu, J.S. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res 2006, 66: 2630-8.
54. Khakoo, A.Y., Pati, S., Anderson, S.A. et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006, 203: 1235-47.
55. Eaton, J., Mitchell, R. and Brewer, B. Embryonic stem cell vaccination prevents lung cancer. Eur J Cancer 2006 2006, 4: Abst 29.
56. Ramasamy, R., Lam, E.W., Soeiro, I., Tisato, V., Bonnet, D. and Dazzi, F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: Impact on in vivo tumor growth. Leukemia 2007, 21: 304-10.
57. Hake, C.R., Graubert, T.A. and Fenske, T.S. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients? Bone Marrow Transplant 2007, 39: 59-70.
58. Gallagher, G. and Forrest, D.L. Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer 2007, 109: 84-92.
59. Nussler, A., Konig, S., Ott, M. et al. Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 2006, 45: 144-59.
60. Kallis, Y., Alison, M.R. and Forbes, S.J. Bone marrow stem cells and liver disease. Gut 2006, Advance publication.
61. Sharma, A.D., Cantz, T., Manns, M.P. and Ott, M. The role of stem cells in physiology, pathophysiology, and therapy of the liver. Stem Cell Rev 2006, 2: 51-8.
62. Yannaki, E., Anagnostopoulos, A., Kapetanos, D. et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol 2006, 34: 1583-7.
63. Gasbarrini, A., Rapaccini, G.L., Rutella, S. et al. Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis 2006, Advance publication.
64. Leung, Y., Geddes, M., Storek, J., Panaccione, R. and Beck, P.L. Hematopoietic cell transplantation for Crohn's disease: is it time? World J Gastroenterol 2006, 12: 6665-73.
65. Taupin, P. OTI-010 Osiris Therapeutics/JCR Pharmaceuticals. Curr Opin Investig Drugs 2006, 7: 473-81.
66. Velkey, J.M., Slawny, N.A., Gratsch, T.E. and O'Shea, K.S. Gene silencing using RNA interference in embryonic stem cells. Methods Mol Biol 2006, 329: 233-61.
67. Muljo, S.A. and Kanellopoulou, C. Mouse embryonic stem cells as a model genetic system to dissect and exploit the RNA interference machinery. Methods Mol Biol 2006, 342: 57-72.
68. Heins, N., Lindahl, A., Karlsson, U. et al. Clonal derivation and characterization of human embryonic stem cell lines. J Biotechnol 2006, 122: 511-20.
69. Heins, N., Englund, M.C., Sjoblom, C. et al. Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 2004, 22: 367-76.
70. Berger, M.J., Adams, S.D., Tigges, B.M. et al. Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. Cytotherapy 2006, 8: 480-7.